COVID-19Regulatory

Early results from Moderna coronavirus vaccine trial show participants developed antibodies against the virus

May 18, 2020 / By Elizabeth Cohen, Senior Medical Correspondent

(CNN) – Study subjects who received Moderna’s Covid-19 vaccine had positive early results, according to the biotech company, which partnered with the National Institutes of Health to develop the vaccine.

If future studies go well, the company’s vaccine could be available to the public as early as January, Dr. Tal Zaks, Moderna’s chief medical officer, told CNN.

“This is absolutely good news and news that we think many have been waiting for for quite some time,” Zaks said.

These early data come from the Phase 1 clinical trial, which typically studies a small number of people and focuses on whether a vaccine is safe and elicits an immune response.

READ THE REST HERE

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button